Comparative effectiveness of first-line pembrolizumab plus chemotherapy, nivolumab plus chemotherapy, and nivolumab plus ipilimumab in metastatic esophageal squamous cell carcinoma: A propensity score-matched real-world analysis.
| Published in: | Journal of Clinical Oncology Vol. 44; pp. 135 - 201 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2026 Supplement 19
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |